Inve US ▾
VTVTRS

Viatris (VTRS) Q1 FY26 earnings call

Earnings call· Mar 2026 (Q1 FY26)· Health Care· May 7, 2026

Source: earnings call transcript

Viatris delivered a strong Q1 FY26, exceeding expectations with robust revenue and EBITDA growth, primarily fueled by exceptional performance in Greater China and solid execution in North America. The company reaffirmed its full-year guidance, citing early-year strength and ongoing pipeline advancements, including key regulatory approvals and upcoming launches. Management emphasized disciplined capital allocation and cost optimization efforts, positioning the company for sustained long-term growth.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.